SCHEMBL5690379

SCHEMBL5690379

O=C(O)Cc1ccc(OC2CCN(C(=O)Oc3ccc(CSc4ncc[nH]4)cc3)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.44
HSD11B1 P28845 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HDAC1 Q13547 1/20 0.37
GPR119 Q8TDV5 1/20 0.36
HRH1 P35367 1/20 0.36
CCR3 P51677 1/20 0.36
KCNH2 Q12809 1/20 0.36
MLNR O43193 3/20 0.35
CHRM2 P08172 1/20 0.35
GAA P10253 1/20 0.35
GRIN2B Q13224 1/20 0.35
FAAH O00519 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
NAMPT P43490 1/20 0.34
NPY2R P49146 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5688122 0.91 EPHX2 (0.42) EPHX2HSD11B1NPC1RAB9AGPR119
SCHEMBL5687804 0.91 SRD5A2 (0.44) EPHX2HSD11B1NPC1RAB9AHDAC1
SCHEMBL5687411 0.88 HSD11B1 (0.41) HSD11B1NPC1RAB9AHDAC1GRIN2B
SCHEMBL5690454 0.85 EPHX2 (0.41) EPHX2NPC1RAB9AGPR119MLNR
SCHEMBL5687712 0.85 LIPE (0.41) EPHX2HSD11B1NPC1RAB9AHDAC1
SCHEMBL5688517 0.83 LIPE (0.44) NPC1RAB9AGPR119
SCHEMBL5691207 0.83 HSD11B1 (0.41) HSD11B1NPC1RAB9AHDAC1GAA
SCHEMBL5688719 0.83 HSD11B1 (0.46) HSD11B1NPC1RAB9AHDAC1GAA
SCHEMBL5687642 0.82 SRD5A2 (0.43) EPHX2HSD11B1NPC1RAB9AHRH1
SCHEMBL5715000 0.81 PANK3 (0.41) RAB9AHDAC1GPR119HRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US claimed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US disclosed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160851-A1 Substituted piperidine carbamates LIPE, PNLIP, LIPC EPHX2 3290/4885HSD11B1 1283/4885NPC1 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.